PINIT Study: Primary Intranasal Insulin Trial

NCT03182322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: intranasal insulin
OTHER: Placebo

Sponsor

Technical University of Munich

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]